MEDIFAST INC Common Stock (MED)

Health and wellness products company USANA Health Sciences (NYSEUSNA) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

Fragrance and perfume company Inter Parfums (NASDAQIPAR) will be announcing earnings results tomorrow after market close. Here’s what you need to know.

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Wellness company Medifast (NYSEMED) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 37.7% year on year to $119 million. On the other hand, next quarter’s revenue guidance of $110 million was less impressive, coming in 15.9% below analysts’ estimates. Its GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024.

Wellness company Medifast (NYSEMED) will be announcing earnings results tomorrow after the bell. Here’s what you need to know.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

Medifast (NYSEMED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle health, digestive health and bone health, and combined with the new plans and OPTAVIA’s holistic offer, fill a critical gap in the weight management market.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medications and their role in health journeys, while also identifying areas where further support is necessary.

What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders. This may have investors wondering how to approach the situation.

Let’s dig into the relative performance of Nu Skin (NYSENUS) and its peers as we unravel the now-completed Q3 personal care earnings season.

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including Olaplex (NASDAQOLPX) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Medifast (NYSEMED).

Wellness products company Nature’s Sunshine Products (NASDAQNATR) will be reporting earnings tomorrow after market hours. Here’s what investors should know.

Personal care company Nu Skin (NYSENUS) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Personal care company Edgewell Personal Care (NYSEEPC) will be announcing earnings results tomorrow before the bell. Here’s what to expect.

Hair care company Olaplex (NASDAQOLPX) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Wellness company Medifast (NYSEMED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s revenue guidance of $110 million was less impressive, coming in 16.4% below analysts’ estimates. Its GAAP profit of $0.10 per share was also 153% above analysts’ consensus estimates.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2024.

Wellness company Medifast (NYSEMED) will be reporting results tomorrow after market hours. Here’s what investors should know.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

MED stock results show that Medifast beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Medifast (NYSEMED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024.